Predicting Microenvironment in CXCR4- and FAP-Positive Solid Tumors-A Pan-Cancer Machine Learning Workflow for

André Marquardt1, Philipp Hartrampf2, Philip Kollmannsberger3

  • 1Department of Pathology, Klinikum Stuttgart, 70174 Stuttgart, Germany.

Cancers
|January 21, 2023
PubMed

Insights

C-X-C Motif Chemokine Receptor 4 (CXCR4) and Fibroblast Activation Protein Alpha (FAP) target distinct tumor microenvironments. CXCR4 positivity indicates an immune-rich niche, while FAP overexpression signals an angiogenic one, aiding theranostic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • C-X-C Motif Chemokine Receptor 4 (CXCR4) and Fibroblast Activation Protein Alpha (FAP) are emerging as key theranostic targets in oncology.
  • The distinct roles of CXCR4 and FAP in defining tumor microenvironments, particularly in solid tumors, remain inadequately understood.

Purpose of the Study:

  • To investigate whether CXCR4 and FAP positivity delineate separate microenvironmental niches across various solid cancers.
  • To identify entity-independent molecular signatures associated with CXCR4 and FAP overexpression.

Main Methods:

  • Utilized Random Forest (RF) analysis on The Cancer Genome Atlas (TCGA) database (n=9242) to identify mRNA and microRNA signatures for CXCR4 and FAP.
  • Performed StringDB cluster analysis, EnrichR, Metascape, and Gene Set Enrichment Analysis (GSEA) for functional enrichment.
  • Validated findings via correlation analyses (n=1541) and assessed immune cell infiltration using TIMER2.0.

Main Results:

  • Identified robust, entity-independent gene signatures for CXCR4 and FAP across most solid cancers.
  • CXCR4 overexpression was associated with an immune-related microenvironment, characterized by CD8+ cell infiltration.
  • FAP overexpression was linked to an angiogenesis-associated niche, with increased endothelial cell infiltration.

Conclusions:

  • CXCR4 and FAP represent distinct theranostic targets, marking separate tumor microenvironmental niches.
  • CXCR4- and FAP-directed PET imaging may offer non-invasive decision support for entity-agnostic microenvironment-targeted therapies.
  • The developed machine learning workflow is adaptable for other theranostic targets.